Total planned funding: $140,644,040
Allocations
Countries/Regions
Ukraine | $140,644,040 |
Organizational Types
Unknown | $35,049,720 |
Private Contractor | $33,590,981 |
NGO | $26,491,184 |
Own Agency | $18,754,001 |
Multi-lateral Agency | $11,125,607 |
University | $5,410,000 |
Implementing Agency | $5,397,040 |
Other USG Agency | $3,225,507 |
Host Country Government Agency | $1,600,000 |
Program Areas
Governance and Systems | $63,934,777 |
Treatment | $24,676,485 |
Prevention | $18,243,372 |
Management and Operations | $13,749,699 |
Care | $10,181,872 |
Testing | $9,857,835 |
Budget Codes
OHSS: Health Systems Strengthening | $33,846,061 |
HVSI: Strategic Information | $18,719,176 |
HVMS: Management and Operations | $13,749,699 |
HTXS: Treatment: Adult Treatment | $13,271,195 |
HTXD: Treatment: ARV Drugs | $11,405,290 |
HLAB: Laboratory Infrastructure | $11,369,540 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $10,675,105 |
HVCT: Testing: HIV Testing and Counseling | $9,857,835 |
HVTB: Care: TB/HIV | $6,961,282 |
HVOP: Sexual Prevention: Other Sexual Prevention | $4,751,444 |
HMBL: Biomedical Prevention: Blood Safety | $2,774,627 |
HBHC: Care: Adult Care and Support | $1,817,824 |
HKID: Care: Orphans and Vulnerable Children | $1,402,766 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $42,196 |
HMIN: Biomedical Prevention: Injection Safety | $0 |
Top Partner Programs
Not Available:
$35,049,720
Countries/Regions
Chemonics International:
$17,819,470
Countries/Regions
USG Aggregated Agencies:
$17,017,414
Countries/Regions
Deloitte Consulting Limited:
$10,671,511
Countries/Regions